Are Gene Scans Effective? Microsoft Funds Research To Find Out

Sign in to queue

The Discussion

  • User profile image
    John Ellis

    Answer: Yes it's effective.


    I did a paper on this last year, nothing fantastic but the evidence is there that it will be effective, we just need to decide HOW to make it get the best effect. It's great that research is being done but with the blindingly obvious problems with Adverse Drug reactions causing death due to pharmacogenetics and at the very least raising healthcare costs it's essential that more scans are done.

    Essentially we need the info ASAP- because your DNA NEVER changes. Introducing scans for everybody will eventually....

    • Mean more drugs make it to market- some get cancelled because of serious ADRs occurring in those who are genetically prone
    • Less big pharmaceutical companies going bust - a drug costs billions to take from test tube to market- failures caused only by some peoples genes could be avoided!
    • Patients could receive the best treatment immediately- dosing and class choices are much easier if you know a person's genome.....
    The list goes on and on and on, the main reason for MS doing this funding is probably to do with Google's links with 23&me ... hopefully this works out, but I doubt a study will show the efficacy of "gene scanning" until the healthcare system has enough people in it who know their genome.

  • User profile image
    John Ellis

    Answer: Yes it's effective.


    I did a paper on this last year, nothing fantastic but the evidence is there that it will be effective, we just need to decide HOW to make it get the best effect. It's great that research is being done but with the blindingly obvious problems with Adverse Drug reactions causing death due to pharmacogenetics and at the very least raising healthcare costs it's essential that more scans are done.

    Essentially we need the info ASAP- because your DNA NEVER changes. Introducing scans for everybody will eventually....

    • Mean more drugs make it to market- some get cancelled because of serious ADRs occurring in those who are genetically prone
    • Less big pharmaceutical companies going bust - a drug costs billions to take from test tube to market- failures caused only by some peoples genes could be avoided!
    • Patients could receive the best treatment immediately- dosing and class choices are much easier if you know a person's genome.....
    The list goes on and on and on, the main reason for MS doing this funding is probably to do with Google's links with 23&me ... hopefully this works out, but I doubt a study will show the efficacy of "gene scanning" until the healthcare system has enough people in it who know their genome.

Add Your 2 Cents